Correction to: Blood Cancer Journal (2018) 8: 68
https://doi.org/10.1038/s41408-018-0103-6;Published online 19 July 2018
Since the publication of the original article the authors noticed the the affiliation details for Paresh Vyas are incorrect. The correct affiliation details for this author are given below:
-
MRC Molecular Haematology Unit, Weatherall Institute of Molecular Medicine and Department of Haematology, University of Oxford and Oxford University Hospitals NHS Trust, Oxford, UK
-
NIHR Oxford Biomedical Research Centre, Oxford, UK
Author information
Authors and Affiliations
Corresponding author
Additional information
Full list of author information is available at the end of the article.
The original article can be found online at https://doi.org/10.1038/s41408-018-0103-6.
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.
About this article
Cite this article
Marquis, M., Beaubois, C., Lavallée, VP. et al. Correction: High expression of HMGA2 independently predicts poor clinical outcomes in acute myeloid leukemia. Blood Cancer J. 9, 28 (2019). https://doi.org/10.1038/s41408-019-0190-z
Published:
DOI: https://doi.org/10.1038/s41408-019-0190-z
